Skip to main content

Stocks to Watch for the coming week


( click to enlarge )
I called  Liminal BioSciences Inc (NASDAQ:LMNL) recently at $4.40 as a potential big runner due to the PDUFA catalyst. On Friday, just a few minutes before the close, the stock was halted and the U.S. Food & Drug Administration (FDA) announced the approval of Ryplazim® (plasminogen, human-tvmh) ("Ryplazim®") for the treatment of patients with plasminogen deficiency type 1 (hypoplasminogenia) through its subsidiary, Prometic Biotherapeutics Inc., holder of the biological license application ("BLA") for Ryplazim®. With this approval, Ryplazim® becomes the first FDA approved therapy for this rare genetic disorder. The closed the after-hours trading gaining more than 55% with 8.2M shares traded. Congratulations to those who bought and profited on LMNL in after-hours, further gains are by no means guaranteed and it never hurts to lock profits in after being up almost 70%. Let's see that $7 break on Monday and see if the stock wants more gains, consolidation, or a pull back. As i tweeted, I took profits in after-hours.
( click to enlarge )
Aprea Therapeutics Inc (NASDAQ:APRE) The last few days the stock has seen increased volume and price. From a technical standpoint, the stock  looks to have bottomed. It broke the falling wedge pattern and could eventually rally up to test its 100-day EMA in the coming days. In addition, MACD, RSI and ADX also indicate positive momentum. To think APRE was trading at $8.4 not long ago.This is worth watching and possibly stepping in for a trade.
( click to enlarge )
Alset Ehome International Inc (NASDAQ:AEI) Friday's close confirms a trend change from downward to neutral in the short-term. Let’s see whether the stock can gather enough momentum to break through $5.11 next week. Huge gap to fill.
( click to enlarge )
I think  Chemomab Therapeutics Ltd (NASDAQ:CMMB) is building a nice base for take off. Some technical indicators are showing positive divergences on a daily basis. We could be in the early stages of a nice rally for this stock. Keep a close eye on it going forward. The stock currently trades at just over $18 a share, but analysts have targets pegged as high as $45 a share, suggesting as much as 120% upside.
( click to enlarge )
Nano Dimension Ltd (NASDAQ:NNDM) This pattern is looking quite good here for higher prices and the stock could break out again very soon. I will keep my eyes on it. The next buy/add point would be when it breaks over 8 on heavy volume. Long-setup on watch.
( click to enlarge )
Criteo (NASDAQ:CRTO) is setting up nicely to break into new highs. Buy point would be on the day it blows through $42.50 on heavy volume.
( click to enlarge )
Celsion Corporation (NASDAQ:CLSN) has been in a bullish consolidation over the last 3 weeks and appears ready for a breakout. Keep on watch.
( click to enlarge )
Ashford Hospitality Trust, Inc. (NYSE:AHT) The stock has been pulling back since hitting a six-month high of $6.13 on June 02. If the pullback continues next week, it would put the 4.4 support and the 200-day EMA into play as the next levels to watch. I like this name a lot.
( click to enlarge )
NetApp (NASDAQ:NTAP) broke above resistance in Friday's trading session after a small period of consolidation. I still like this stock and will be watching it again on Monday, expecting to see a continuation move.
During the day I tweet many times to my readers. I encourage everybody to subscribe AC Investor Blog twitter and newsletter, so you can receive my trade ideas and stock news in real time.
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Thanks for visiting AC Investor Blog.

AC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.